Roles of gastrointestinal hormones in pancreatic cancer

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 7, Issue 3, 2000, Pages 276-285

  Guo, Yan Shi ^a   Townsend Jr , Courtney M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Bombesin; Cholecystokinin; Gastrin; Metastasis; Pancreatic cancer

Indexed keywords

BOMBESIN; CARCINOGEN; CHOLECYSTOKININ; GASTRIN; GASTROINTESTINAL HORMONE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL; HAMSTER; HUMAN; LYMPH NODE METASTASIS; METABOLISM; PANCREAS; PANCREAS TUMOR; PATHOLOGY; RAT; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ANIMALS; BOMBESIN; CARCINOGENS; CHOLECYSTOKININ; CRICETINAE; GASTRINS; GASTROINTESTINAL HORMONES; HUMANS; LYMPHATIC METASTASIS; PANCREAS; PANCREATIC NEOPLASMS; RATS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033660553     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340070049     Document Type: Article

References (118)

1. Townsend CM Jr, Bold RJ, Ishizuka J (1994) Gastrointestinal hormones and cell proliferation. Surg Today 24:772-777
2. Guo Y-S, Townsend CM Jr (1999) Gastrointestinal hormones and gastrointestinal cancer growth. In: Greeley GH Jr (ed) Gastrointestinal endocrinology. Humana Press, New Jersey, pp 189-214
3. Logsdon CD (1999) Role of cholecystokinin in physiologic and pathophysiologic growth of the pancreas. In: Greeley GH Jr (ed) Gastrointestinal endocrinology. Humana Press. New Jersey, pp 393-422
4. Preston SR, Miller GV, Primrose JN (1996) Bombesin-like peptides and cancer. Crit Rev Oncol Hematol 23:225-238
5. Jiang S, Kopras E, McMichael M, Bell RH Jr, Ulrich CD 2nd (1997) Vasoactivc intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Cancer Res 57:1475-1480
6. Townsend CM Jr, Thompson JC (1995) The clinical use of gastrointestinal hormones for alimentary tract disease. Adv Surg 29:79-92
7. Owyang C, Louie DS, Tatum D (1986) Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. J Clin Invest 77:2042-2047
8. Booth AN, Robbins DJ, Ribelin WE, DeEds F (1960) Effect of raw soybean meal and amino acids on pancreatic hypertrophy in rats. Proc Soc Exp Biol Med 104:681-683
9. Nishimuri I, Kamakura M, Fujikawa-Adachi K, Nojima M, Onishi S, Hollingsworth MA, Harris A (1999) Cholecystokinin A and B receptor mRNA expression in human pancreas. Pancreas 19:109-113
10. Wank SA, Harkins R, Jensen RT, Shapira H, de Weerth A, Slattery T (1992) Purification. molecular cloning. and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 89:3125-3129
11. Zhou W, Povoski SP, Rosen NA, Longnecker DS, Bell RH Jr (1994) Characterization of cholecystokinin receptors in rat pancreas. Evidence for expression of CCK-A receptor but not CCK-B (gastrin) receptors. Ann NY Acad Sci 713:331-333
12. Monstein HJ, Nylander AG, Salehi A, Chen D, Lundquist I, Hakanson R (1996) Cholecystokinin-A and cholecystokinin-B gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand J Gastroenterol 31:383-390
13. Tang C, Biemond I, Offerhaus GJ, Verspaget W, Lamers CB (1997) Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. Br J Cancer 75:1467-1473
14. Weinberg DS, Ruggeri B, Barber MT, Biswas S, Miknyocki S, Waldman SA (1997) Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest 100:597-603
15. Chey W (1993) Hormonal control of pancreatic exocrine secretion. In: Go V (ed) The pancreas: biology pathobiology and disease. Raven, New York, pp 403-424
16. Seva C, Dickinson CJ, Yamada T (1994) Growth-promoting effects of glycine-extended progastrin. Science 265:410-412
17. Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC (1994) Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-B. Biochem Biophys Res Commun 202:1222-1226
18. Hellmich MR, Iwase K, Guo Y-S, Martinez J, Laur J, Townsend CM Jr (1997) Gastrin and glycine-extended gastrin stimulated kidney cell growth is mediated by a novel gastrin receptor subtype (abstract). Gastroenterology 112:1154
19. Singh P, Xu, Z, Dai R, Rajaraman S, Rubin N, Dhruva B (1994) Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins. Am J Physiol 266:G459-468
20. Stepan VM, Krametter DF, Matsushima M, Todisco A, Delvalle J, Dickinson CJ (1999) Glycine-extended gastrin regulates HEK cell growth. Am J Physiol 277:R572-581
21. Baldwin GS (1995) Binding of progastrin fragments to the 78-kDa gastrin-binding protein. FEBS Lett 359:97-100
22. Baldwin GS (1994) Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein. Proc Natl Acad Sci USA 91:7593-7597
23. Monstein HJ, Nylander AG, Hakanson R (1997) Widespread tissue expression of gastrin-binding-protein mRNA. Eur J Biochem 246:502-507
24. Smith JF, Verderame MF, Mclaughlin PJ, Zagon IS (1999) Characterization of the CCK-C (Cancer) receptor in human pancreatic cancer. Gastroenterology 116:A5047
25. Kurosawa M, Bucinskaite V, Taniguchi T, Miyasaka K, Funakoshi A, Lundeberg T (1999) Response of the gastric vagal afferent activity to cholecystokinin in rats lacking type A cholecystokinin receptors. J Auton Nerv Syst 75:51-59
26. Guo Y-S, Rui XL, Martinez J, Townsend CM Jr, Hellmich MR (1999) Glycine-extended gastrin activated CCK-B receptors and stimulates proliferation of RIE cells (abstract). Gastroenterology 116:608
27. McGuinness EE, Morgan RG, Wormsley KG (1984) Effects of soybean flour on the pancreas of rats. Environ Health Perspect 56:205-212
28. McGuinness EE, Morgan RG, Levison DA, Frape DL, Hopwood D, Wormsley KG (1980) The effects of long-term feeding of soya Hour on the rat pancreas. Scand J Gastroenterol 15:497-502
29. McGainness EE, Morgan RG, Wormsley KG (1987) Fate of pancreatic nodules induced by raw soya flour in rats. Gut 28:207-212
30. Stazz NH, Palmer TJ, Vaja S, Dowling RH (1987) Longterm pancreativaticobiliary diversion stimulates hyperplastic and adsnomatous nodules in the rat pancreas: a new model for spontaneous tumour formation. Gut 28:265-268
31. Longnecker DS (1993) Experimental models of exocrine pancreatic tumors. In: Go V (ed) The pancreas: biology, pathobiology, and disease. Raven, New York, pp 551-564
32. van Kranen HJ, Vermeulen E, Schoren L, Bax J, Woutersen RA, van Jersel P, van Kreijl CF, Scherer E (1991) Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. Carcinogenesis 12:1477-1482
33. Lujii H, Egami H, Chaney W, Pour P, Felling J (1990) Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog 3:296-301
34. Cerny WL, Mangold KA, Scarpelli DG (1992) K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res 52:4507-4513
35. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554
36. Douglas RR, Woutersen RA, Jansen JB, de Jong AJ, Rovati LC, Lamers CB (1989) Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Gastroenterology 96:462-469
37. Douglas BR, Woutersen RA, Jansen JB, de Jong AJ, Rovati LC, Lamers CB (1989) Modulation by CR-1409 (lorglumide). a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Cancer Res 49:2438-2441
38. Meijers M, Appel MJ, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jansen JB, Woutersen RA (1992) Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide. Carcinogenesis 13:1525-1528
39. Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH Jr (1994) Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Ann N Y Acad Sci 713:439-441
40. Appel MJ, Meijers M, Van Garderen-Hoetmer A, Lamers CB, Rovati LC, Sprij-Mooij D, Jansen JB, Woutersen RA (1992) Role of cholecystokinin in dietary fat-promoted azascrine-induced pancreatic carcinogenesis in rats. Br J Cancer 66:46-50
41. Morgan RG, Levinson DA, Hopwood D, Saunders JH, Wormsley KG (1977) Potentiation of the action of azaserine on the rat pancreas by raw soya bean flour. Cancer Lett 3:87-90
42. Roebuck BD, Kaplita PV, Edwards BR, Praissman M (1987) Effects of dietary fats and soybean protein on azascrine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. Cancer Res 47:1333-1338
43. Daly JM, Morgan RG, Gates PS, Yeoh GC, Tee LB (1992) Azaserine-induced pancreatic foci: detection, growth, labelling index and response to raw soya flour. Carcinogenesis 13:1519-1523
44. Herrington MK, Permert J, Kazakoff KR, Pour PM, Zuker KA, Bilchik AJ, Adrian TE (1993) Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster. Carcinogenesis 14:1021-1026
45. Watanapa P, Flaks B, Oztas H, Deprez PH, Calam J, Williamson RC (1992) Enhancing effect of partial gastrectomy on pancreatic carcinogenesis. Br J Cancer 65:383-387
46. Watanapa P, Flaks B, Oztas H, Deprez PH, Calam J, Williamson RC (1992) Duodenogastric reflux enhances growth and carcinogenesis in the rat pancreas. Br J Surg 79:791-794
47. Watanapa P, Flaks B, Oztas H, Deprez PH, Calam J, Williamson RC (1993) Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion. Br J Cancer 67:663-667
48. Zhou W, Povoski SP, Longnecker DS, Bell RH Jr (1992) Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Cancer Res 52:6905-6911
49. Povoski SP, Zhou W, Longnecker DS, Bell RH Jr (1993) Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis. Pancreas 8:615-621
50. Zhou W, Povoski SP, Bell RH Jr (1993) Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma. Carcinogenesis 14:2189-2192
51. Bell RH Jr, Kuhlmann ET, Jensen RT, Longnecker DS (1992) Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. Cancer Res 52:3295-3299
52. Howatson AG, Carter DC (1985) Pancreatic carcinogenesis -enhancement by cholecystokinin in the hamster-nitrosamine model. Br J Cancer 51:107-114
53. Chu M, Rehfeld JF, Borch K (1997) Chronic endogenous hypercholecystokininemia promotes pancreatic carcinogenesis in the hamster. Carcinogenesis 18:315-320
54. Herrington MK, Permert J, Kazakoff KR, Zucker KA, Bilchik AJ, Pour PM, Adrian TH (1994) Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster. Cancer Lett 82:7-16
55. Hasdai A, Liener IE (1986) The failure of long-term feeding of raw soy flour, in the presence or absence of azaserine, to induce carcinogenic changes in the mouse pancreas. Nutr Cancer 8:85-91
56. Furukawa F, Imaida K, Okamiya H, Shinoda K, Sato M, Imazawa T, Hayashi Y, Takahashi M (1991) Inhibitory effects of soybean trypsin inhibitor on induction of pancreatic neoplastic lesions in hamsters by N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 12:2123-2125
57. Furukawa F, Nishikawa A, Imaida K, Mitsui M, Enami T, Hayashi Y, Takahashi M (1992) Inhibitory effects of crude soybean trypsin inhibitor on pancreatic ductal carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 13:2133-2135
58. Corra S, Kazakoff K, Lawson TA, Adrian TE, Pour PM (1992) Cholecystokinin inhibits DNA alkylation induced by N-nitrosobis(2-oxopropyl)amine (BOP) in hamster pancreas. Cancer Lett 62:251-256
59. Gumbmann MR, Dugan GM, Spangler WL, Baker EC, Rackis JJ (1989) Pancreatic response in rats and mice to trypsin inhibitors from soy and potato after short- and long-term dietary exposure. J Nutr 119:1598-1609
60. Meijers M, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jausen JB, Woutersen RA (1991) Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters. Cancer Lett 60:205-211
61. Kaufmann R, Schafberg H, Rudroff C, Henklein P, Nowak G (1997) Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth. Neuropeptides 31:573-583
62. Swift IR, Smith JP (1994) Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer. Dig Dis Sci 39:1007-1013
63. Heald EB, Kramer ST, Smith JP (1992) Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer. Pancreas 7:530-535
64. Smith JP, Kramer ST, Solomon TE (1991) CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. Regul Pept 32:341-349
65. Smith JP, Rickabaugh CA, McLaughlin PJ, Zagon IS (1993) Cholecystokinin receptors and rANC-1 human pancreatic cancer cells. Am J Physiol 265:G149-155
66. Smith JP, Solomon TE, Bagheri S, Kramer S (1990) Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci 35:1377-1384
67. Smith JP, Kramer S, Bagheri S (1990) Effects of a high-fat diet and L364,718 on growth of human pancreas cancer. Dig Dis Sci 35:726-732
68. Frazier ML, Pathak S, Wang ZW, Cleary K, Singletary SE, Olive M, Mackay B, Steck PA, Levin B (1990) Establishment of a new human pancreatic adenocarcinoma cell line. MDAPanc-3. Pancreas 5:8-16
69. Townsend CM Jr, Franklin RB, Watson LC, Glass EJ, Thompson JC (1981) Stimulation of pancreatic cancer growth by caerulein and secretin. Surg Forum 32:228-229
70. Townsend CM Jr, Franklin RB, Gelder FB, Glass E, Thompson JC (1982) Development of a transplantable model of pancreatic duct adenocarcinoma. Surgery 92:72-78
71. Alexander RW, Upp JR Jr, Singh P, Hugh T, Poston GJ, Townsend CM Jr, Thompson JC (1987) Asperlicin inhibits the growth of a xenografted human pancreatic carcinoma. Gastroenterology 92:1293
72. Jamshidipour R, Pinho EB, Howell SB (1994) In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenografts. Anticancer Res 14:2611-2616
73. Shivaram S, Crist KA, Chaudhuri B, Mucci SJ, Chaudhuri PK (1992) Effect of CCK receptor antagonist on growth of pancreatic adenocarcinoma. J Surg Res 53:234-237
74. Smith JP, Fantaskey AP, Liu G, Zagon IS (1995) Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physiol 268:R135-141
75. Blackmore M, Hirst BH (1992) Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. Br J Cancer 66:32-38
76. Liehr RM, Melnykovych G, Solomon TE (1990) Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2. Gastroenterology 98:1666-1674
77. Robertson JK, Watson SA, Hardcastle JD (1995) Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer. Int J Cancer 63:69-75
78. Detjen K, Fenrich MC, Logsdon CD (1997) Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines. Gastroenterology 112:952-959
79. Karsenty L, Hajri A, Aprahamian M, Garaud JC, Doffoel M, Damge C (1993) Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8. Pancreas 8:204-211
80. Hudd C, Euhus DM, LaRegina MC, Herbold DR, Palmer DC, Johnson FE (1985) Effect of cholecystokinin on human cholangiocarcinoma xenografted into nude mice. Cancer Res 45:1372-1377
81. Hudd C, LaRegina MC, Devine JE, Palmer DC, Herbold DR. Beinfeld MC, Gelder FB, Johnson FE (1989) Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice. Am J Surg 157:386-394
82. Hugh T, Alexander RW, Upp JR Jr, Poston GJ, Schauweker T, Singh P, Townsend CM Jr, Thompson JC (1987) Caerulcin inhibits growth of a human cholangiocarcinoma with cholecystokinin receptors. Gastroenterology 92:1801
83. Evers BM, Gomez G, Townsend CM Jr, Rajaraman S, Thompson JC (1989) Endogenous cholecystokinin regulates growth of human cholangiocarcinoma. Ann Surg 210:317-322
84. Abbruzzese JL, Gholson CF, Daugherty K, Larson E, DuBrow R, Berlin R, Levin B (1992) A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer. Pancreas 7:165-171
85. Militello C, Sperti C, Di Prima F, Pedrazzoli S (1997) Clinical evaluation and safety of loxiglumide (CCK-A receptor antagonist) in nonresectable pancreatic cancer patients. Italian Pancreatic Cancer Study Group. Pancreas 14:222-228
86. Upp JR Jr, Poston GJ, MacLellan DG, Townsend CM Jr. Barranco SC, Thompson JC (1988) Mechanisms of the trophic actions of bombesin on the pancreas. Pancreas 3:193-198
87. Wang QJ, Knezetic JA, Schally AV, Pour PM, Adrian TE (1996) Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway. Int J Cancer 68:528-534
88. Lhoste EF, Longnecker DS (1987) Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas. Cancer Res 47:3273-3277
89. Meijers M, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jansen JB, Woutersen RA (1991) Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters. Cancer Lett 59:45-50
90. Szepeshazi K, Schally AV, Cai RZ, Radulovic S, Milovanovic S, Szoke B (1991) Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatosiatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Cancer Res 51:5980-5986
91. Rosewicz S, Detjen K, Kaiser A, Prosene N, Cervos-Navarro J, Riecken EO, Haller H (1994) Bombesin receptor gene expression in rat pancreatic acinar AR42J cells: transcriptional regulation by glucocorticoids. Gastroenterology 107:208-218
92. Singh P, Draviam E, Guo YS, Kurosky A (1990) Molecular characterization of bombesin receptors on rat pancreatic acinar AR42J cells. Am J Physiol 258:G803-809
93. Hajri A, Balboni G, Koenig M, Garaud JC, Damge C (1992) Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma. Cancer Res 52:3726-3732
94. Hajri A, Koenig M, Balboni G, Damge C (1996) Expression and characterization of gastrin-releasing peptide receptor in normal and cancerous pancreas. Pancreas 12:25-35
95. Szepeshazi K, Schally AV, Cai R-Z, Halmos G, Groot K (1996) Effects of new bombesin antagonists given singly or in combination with a somatostatin analog on nitrosamine-induced pancreatic cancers in hamsters. Int J Oncol 9:397-403
96. Avis I, Jett M, Kasprzyk PG, Cuttitta F, Treston AM, Maneckjee R. Mulshine JL (1993) Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan). Mol Carcinog 8:214-220
97. Farre A, Ishizuka J, Gomez G, Evers BM, Saydjari R, Koo JY, Townsend CM Jr, Thompson JC (1994) Bombesin inhibits growth of pancreatic ductal adenocarcinoma (H2T) in nude mice. Pancreas 9:652-656
98. Alexander RW, Upp JR Jr, Poston GJ, Townsend CM Jr, Singh P. Thompson JC (1988) Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice. Pancreas 3:297-302
99. Szepeshazi K, Schally AV, Groot K, Halmos G (1993) Effect of bombesin, gastrin-releasing peptide (GRP) (14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters. Int J Cancer 54:282-289
100. Qin Y, Ertl T, Cai RZ, Halmos G, Schally AV (1994) Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res 54:1035-1041
101. Douziech N, Calvo E, Laine J, Morisset J (1999) Activation of MAP kinases in growth responsive pancreatic cancer cells. Cell Signal 11:591-602
102. Qin Y, Ertl T, Cai RZ, Horvath JE, Groot K, Schally AV (1995) Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP. Int J Cancer 63:257-262
103. Szepeshazi K, Halmos G, Schally AV, Arencibia JM, Groot K, Vadillo-Buenfil M, Rodriguez-Martin E (1999) Growth inhihitoin of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs. J Cancer Res Clin Oncol 125:444-452
104. Upp JR Jr, Trudel JL, Townsend CM Jr, Alexander RW, Rajaraman S, Nealon WH, Greeley GH Jr, Thompson JC (1988) Establishment of a human gastrinoma in nude mice. Surgery 104 1037-1045
105. Chung DH, Evers BM, Beauchamp RD, Upp JR Jr, Rajaraman S, Townsend CM Jr, Thompson JC (1992) Bombesin stimulates growth of human gastrinoma. Surgery 112:1059-1065
106. Saurin JC, Rouault JP, Abello J, Berger F, Remy L, Chayvialle JA (1999) High gastrin releasing peptide receptor mRNA level is related to tumour dedifferentiation and lymphatic vessel invasion in human colon cancer. Eur J Cancer 35:125-132
107. Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer 80:1529-1537
108. Aprikian AG, Tremblay L, Han K, Chevalier S (1997) Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int J Cancer 72:498-504
109. Pestuccia C, Guerra F, D'Ascenzo S, Giuneiuglio D, Albini A, Bologna M (1998) In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int J Cancer 75: 418-431
110. Hoosein NM, Logothetis CJ, Chung LW (1993) Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J Urol 149:1209-1213
111. Ishi H, Tatsuta M, Baba M, Uehara H, Nakaizumi A (1994) Ornithine decarboxylase inhibitor attenuates bombesin enhancement of intestinal carcinogenesis and metastasis induced by azoxymethane. Int J Cancer 58:533-537
112. Iishi H, Tatsuta M, Baba M, Uehara H, Nakaizumi A, Shinkai K, Akedo H, Funai H, Ishiguro S, Kitagawa I (1997) Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis 15:603-611
113. Saurin JC, Nemoz-Gaillard E, Sordat B, Cuber JC, Coy DH, Abello J, Chayvialle JA (1999) Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isrecol cell line. Cancer Res 59:962-967
114. Taniguchi T, Matsui T, Ito M, Murayama T, Tsukamoto T, Katakami Y, Chiba T, Chihara K (1994) Cholecystokinin-B/gastrin receptor signaling pathway involves tyrosine phosphorylations of p125FAK and p42MAP. Oncogene 9:861-867
115. Taniguchi T, Takaishi K, Murayama T, Ito M, Iwata N, Chihara K, Sasaki T, Takai Y, Matsui T (1996) Cholecystokinin-B/gastrin receptors mediate rapid formation of actin stress fibers. Oncogene 12:1357-1360
116. Hirata M, Itoh M, Tsuchida A, Ooishi H, Hanada K, Kajiyama G (1996) Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS Lett 383:241-244
117. Hirata M, Tsuchida A, Iowa T, Sasaki T, Matsubara K, Yamamoto S, Morinaka K, Kawasaki Y, Fujimoto Y, Inoue H, Kariya K, Kajiyama G (1999) Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway. Int J Oncol 14:1129-1135
118. Detjen K, Yule D, Tseng MJ, Williams JA, Logsdon CD (1997) CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells. Am J Physiol 273:C1449-1457